Related Experiment Videos
A lymphoma growth inhibitor blocks some but not all prolactin-stimulated signaling pathways
1Department of Pathology, Uniformed Services University of the Health Sciences School of Medicine, Bethesda, Maryland 20814, USA.
Abstract:
Cytokines and hormones activate a network of intracellular signaling pathways to regulate cell division, survival and differentiation. In parallel, a series of growth inhibitory mechanisms critically restrict cell population sizes. For example, mitogens can be opposed in crowded cell cultures through contact-inhibition or by autocrine release of antiproliferative substances. Here, we characterize a small, heat-stable growth inhibitor secreted by a rat T lymphoma line when cultured at high cell density. Short term incubation (<60 min) of prolactin-responsive Nb2 lymphoma cells at high density selectively blocked prolactin stimulation of p42/p44 mitogen-activated protein kinases and transcription factors Stat1 and Stat3 but not prolactin activation of Stat5 or the tyrosine kinase Jak2. The selective effects of cell density on prolactin signaling were reversible. Furthermore, exposure of cells at low density to conditioned media from cells incubated at high density had the same inhibitory effects on prolactin signaling. This selective inhibition of discrete prolactin signals was mimicked by short term preincubation of cells at low density with staurosporine or genistein but not with bis-indoleyl maleimide, cyclic nucleotide analogs, calcium ionophore A23187, or phorbol 12-myristate 13-acetate. A heat-stable, proteinase K-resistant, low molecular weight factor with these characteristics was recovered from high density culture medium. The partially purified inhibitor suppressed Nb2 cell growth with a sigmoidal concentration response consistent with a saturable, receptor-mediated process.
Insights
High cell density releases a heat-stable inhibitor that selectively blocks prolactin signaling pathways, impacting cell growth. This secreted factor offers insights into growth regulation and potential therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Endocrinology
- Biochemistry
Background:
- Cell growth is regulated by a balance of stimulatory and inhibitory signals.
- Mechanisms like contact inhibition and autocrine factors limit cell proliferation in dense cultures.
- Understanding these inhibitory pathways is crucial for controlling cell population dynamics.
Purpose of the Study:
- To characterize a novel growth inhibitor secreted by rat T lymphoma cells at high density.
- To investigate the specific effects of this inhibitor on prolactin signaling pathways in Nb2 lymphoma cells.
- To identify the biochemical properties and mechanism of action of the secreted inhibitor.
Main Methods:
- Incubation of prolactin-responsive Nb2 lymphoma cells at high and low densities.
- Analysis of prolactin-stimulated signaling pathways, including mitogen-activated protein kinases and transcription factors (Stat1, Stat3, Stat5).
- Biochemical characterization of the inhibitor (heat stability, proteinase K resistance, molecular weight) and assessment of its effects on cell growth.
Main Results:
- High cell density selectively inhibited prolactin stimulation of p42/p44 mitogen-activated protein kinases, Stat1, and Stat3, but not Stat5 or Jak2.
- The inhibitory effects were reversible and mimicked by conditioned medium from high-density cultures.
- A heat-stable, low molecular weight inhibitor was isolated, which suppressed Nb2 cell growth via a saturable, receptor-mediated process.
Conclusions:
- A novel, secreted inhibitor regulates cell density-dependent growth by selectively interfering with specific prolactin signaling cascades.
- This inhibitor represents a key component of autocrine growth control mechanisms in T lymphoma cells.
- The findings provide insights into the molecular basis of contact inhibition and offer potential targets for modulating cell proliferation.